NL190702C - 4H-pyrido[1,2-a]pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan. - Google Patents

4H-pyrido[1,2-a]pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.

Info

Publication number
NL190702C
NL190702C NL7805534A NL7805534A NL190702C NL 190702 C NL190702 C NL 190702C NL 7805534 A NL7805534 A NL 7805534A NL 7805534 A NL7805534 A NL 7805534A NL 190702 C NL190702 C NL 190702C
Authority
NL
Netherlands
Prior art keywords
pyrido
pyrimidin
compound
well
pharmaceutical preparation
Prior art date
Application number
NL7805534A
Other languages
English (en)
Dutch (nl)
Other versions
NL190702B (nl
NL7805534A (nl
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NL7805534A publication Critical patent/NL7805534A/xx
Publication of NL190702B publication Critical patent/NL190702B/xx
Application granted granted Critical
Publication of NL190702C publication Critical patent/NL190702C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
NL7805534A 1977-05-25 1978-05-22 4H-pyrido[1,2-a]pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan. NL190702C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/800,264 US4122274A (en) 1977-05-25 1977-05-25 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Publications (3)

Publication Number Publication Date
NL7805534A NL7805534A (nl) 1978-11-28
NL190702B NL190702B (nl) 1994-02-01
NL190702C true NL190702C (nl) 1994-07-01

Family

ID=25177928

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7805534A NL190702C (nl) 1977-05-25 1978-05-22 4H-pyrido[1,2-a]pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.

Country Status (26)

Country Link
US (1) US4122274A (OSRAM)
JP (1) JPS6050197B2 (OSRAM)
AT (1) AT365187B (OSRAM)
AU (1) AU521211B2 (OSRAM)
BE (1) BE867295A (OSRAM)
CA (1) CA1098520A (OSRAM)
CH (1) CH642656A5 (OSRAM)
CY (1) CY1218A (OSRAM)
DE (1) DE2822544A1 (OSRAM)
DK (1) DK160279C (OSRAM)
FI (1) FI64594C (OSRAM)
FR (1) FR2401159A1 (OSRAM)
GB (1) GB1596476A (OSRAM)
GR (1) GR71887B (OSRAM)
HK (1) HK25884A (OSRAM)
IE (1) IE46849B1 (OSRAM)
IT (1) IT1105040B (OSRAM)
KE (1) KE3357A (OSRAM)
LU (1) LU79694A1 (OSRAM)
MY (1) MY8500305A (OSRAM)
NL (1) NL190702C (OSRAM)
NO (1) NO150361C (OSRAM)
SE (1) SE437830B (OSRAM)
SG (1) SG73383G (OSRAM)
YU (2) YU42163B (OSRAM)
ZA (1) ZA782816B (OSRAM)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
US4192944A (en) * 1978-04-03 1980-03-11 Bristol-Myers Company Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4474953A (en) * 1982-09-09 1984-10-02 Riker Laboratories, Inc. Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
DK169580B1 (da) * 1985-09-25 1994-12-12 Shionogi & Co 9-(substitueret thio)-4H-pyrido[1,2-a]pyrimidin-4-on-derivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende sådanne derivater
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
JPS62242682A (ja) * 1986-04-16 1987-10-23 Tokyo Tanabe Co Ltd 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤
JPH0662417B2 (ja) * 1987-12-25 1994-08-17 参天製薬株式会社 抗アレルギー点眼液
CA2010336C (en) * 1989-02-27 1996-11-19 Atsunori Sano Process for producing pyrido[1,2-a]pyrimidine derivative
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
AU674016B2 (en) 1992-07-30 1996-12-05 Mitsubishi-Tokyo Pharmaceuticals, Inc. Remedy for inflammatory intestinal diseases
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
JPH0892093A (ja) * 1994-11-10 1996-04-09 Tokyo Tanabe Co Ltd ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤
KR100885007B1 (ko) * 2001-02-26 2009-02-20 미쓰비시 타나베 파마 코퍼레이션 신질환·신부전의 예방 또는 치료를 위한 약학 조성물
ITMI20011764A1 (it) * 2001-08-10 2003-02-10 Dinamite Dipharma Spa Metodo per l'ottenimento del pemirolast ad elevata purezza
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
SI2120919T1 (sl) * 2006-12-18 2012-12-31 Cardoz Ab Nova kombinacija za uporabo pri zdravljenju vnetnih obolenj
CA2673214A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
EP2175845A2 (en) * 2007-07-11 2010-04-21 Cardoz AB New combination for use in the treatment of inflammatory disorders
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
ES2395002T3 (es) * 2008-04-07 2013-02-07 Cardoz Ab Nueva combinación para uso en el tratamiento de trastornos inflamatorios
DK2443120T3 (en) * 2009-06-16 2017-01-09 Rspr Pharma Ab Crystalline form of pemirolast
USD661900S1 (en) 2010-02-22 2012-06-19 Bajer Design & Marketing, Inc. Collapsible structure
BR112014019750B1 (pt) * 2012-02-10 2020-03-03 F. Hoffmann-La Roche Ag. Composto, composição farmacêutica e seus usos
MX352962B (es) 2012-03-01 2017-12-15 Ptc Therapeutics Inc Compuestos para tratar atrofia muscular espinal.
US9914722B2 (en) 2012-03-23 2018-03-13 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EP3082820B1 (en) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
US20160243122A1 (en) 2014-10-23 2016-08-25 Rspr Pharma Ab Use of pemirolast in the treatment of acute asthma
WO2016102941A1 (en) 2014-12-22 2016-06-30 Rspr Pharma Ab New combination of pemirolast and montelukast
EP3298017B1 (en) * 2015-05-20 2019-08-14 H. Hoffnabb-La Roche Ag Compounds for treating spinal muscular atrophy
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
GB201518831D0 (en) 2015-10-23 2015-12-09 Rspr Pharma Ab New use
MX391850B (es) 2015-12-10 2025-03-19 Ptc Therapeutics Inc Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
GB201601138D0 (en) * 2016-01-21 2016-03-09 Rspr Pharma Ab New use
CA3043755A1 (en) 2016-11-28 2018-05-31 Ptc Therapeutics, Inc. Methods for modulating rna splicing
SG11201911615WA (en) 2017-06-05 2020-01-30 Ptc Therapeutics Inc Compounds for treating huntington's disease
BR112019026508A2 (pt) 2017-06-14 2020-07-14 Ptc Therapeutics, Inc. métodos para modificar o splicing do rna
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
WO2019005980A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
AU2019243048A1 (en) 2018-03-27 2020-10-15 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
EP3814360B8 (en) 2018-06-27 2024-11-06 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
MX2020014098A (es) 2018-06-27 2021-05-27 Ptc Therapeutics Inc Compuestos heterocíclicos y de heteroarilo para tratar la enfermedad de huntington.
BR112020026534A2 (pt) 2018-06-27 2021-03-23 Ptc Therapeutics, Inc. Compostos de heteroarila para o tratamento da doença de huntington

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
AT302311B (de) * 1966-11-02 1972-09-15 Chinoin Gyogyszer Es Vegyeszet Verfahren zur herstellung von homopyrimidazol-derivaten und deren saeureadditionssalzen und quaternaeren ammoniumsalzen
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4012387A (en) * 1975-09-18 1977-03-15 Warner-Lambert Company Benzo-[g]pyrido[2,1-b]quinazolinones

Also Published As

Publication number Publication date
SE7805954L (sv) 1978-11-26
FI781614A7 (fi) 1978-11-26
GB1596476A (en) 1981-08-26
DK160279B (da) 1991-02-18
CA1098520A (en) 1981-03-31
NO150361B (no) 1984-06-25
FI64594C (fi) 1983-12-12
YU44212B (en) 1990-04-30
FR2401159B1 (OSRAM) 1983-05-20
BE867295A (fr) 1978-11-20
IT1105040B (it) 1985-10-28
YU42163B (en) 1988-06-30
FR2401159A1 (fr) 1979-03-23
NL190702B (nl) 1994-02-01
IT7849523A0 (it) 1978-05-24
DK228878A (da) 1978-11-26
ATA373278A (de) 1981-05-15
DE2822544A1 (de) 1978-12-07
JPS5436294A (en) 1979-03-16
LU79694A1 (fr) 1979-02-02
SG73383G (en) 1984-08-03
FI64594B (fi) 1983-08-31
DE2822544C2 (OSRAM) 1988-10-27
DK160279C (da) 1991-07-22
IE781036L (en) 1978-11-25
NO781786L (no) 1978-11-28
ZA782816B (en) 1979-05-30
AT365187B (de) 1981-12-28
HK25884A (en) 1984-03-30
JPS6050197B2 (ja) 1985-11-07
KE3357A (en) 1984-02-03
AU521211B2 (en) 1982-03-25
NL7805534A (nl) 1978-11-28
CH642656A5 (de) 1984-04-30
YU123678A (en) 1983-02-28
NO150361C (no) 1984-10-03
SE437830B (sv) 1985-03-18
YU233082A (en) 1988-08-31
AU3631978A (en) 1979-11-29
CY1218A (en) 1984-04-06
GR71887B (OSRAM) 1983-08-04
MY8500305A (en) 1985-12-31
IE46849B1 (en) 1983-10-05
US4122274A (en) 1978-10-24

Similar Documents

Publication Publication Date Title
NL190702C (nl) 4H-pyrido[1,2-a]pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.
MA19107A1 (fr) Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one .
DK161559C (da) Stol, isaer dataterminal-stol
NL190519C (nl) 4-Gesubstitueerde fenylazijnzuurverbindingen, alsmede farmaceutische preparaten.
NL7709442A (nl) Werkwijze voor imidazo-(1,2-a)-chinoline-2- -carbonzuurderivaten.
HU178496B (en) Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity
NL185622B (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede 7beta-acylamino-7alfa-methoxy-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur.
DK495287D0 (da) 2-eller 3-arylsubstituerede imidazo(1,2-a)pyridi ner
ES2017932B3 (es) Compuestos azaciclicos, procedimientos de su preparacion y su uso como farmacos.
NL7811220A (nl) Cefalosporanzuurderivaten, werkwijzen voor de bereiding daarvan, farmaceutische preparaten.
KR880701719A (ko) 아자인돌 및 인돌리진 유도체, 이들의 제조방법 및 이들 약제로서의 용도
AU518364B2 (en) Pyrido 1, 2 pyrimidine derivatives
NL7711446A (nl) Pharmaceutische desinfecterend preparaat.
AU516933B2 (en) Medicine with activity as prostaglandinsynthetase
IT8021821A0 (it) Pirido [1,2-a] pirimidine sostituite
IT8048968A0 (it) Composti 2,4-diamminopirido (2,3-d)pirimidinici dotati di attivita'farmacologica e procedimento per laloro preparazione
DE2860410D1 (en) 2-piperazinotetraline derivatives, their preparation and their use as medicines
NL7801469A (nl) Nieuwe imidazo (1,5-b)-pyradizinen met farma- ceutische activiteit.
FI853027A0 (fi) Imidazo/1,2-a/kinoliner, deras framstaellning och deras terapeutiska tillaempning.
NL7803122A (nl) Nieuwe pyrido(2,1-b)-chinazolinederivaten met geneeskrachtige activiteit en werkwijzen om deze te bereiden.
IT8023101A0 (it) Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare.
FI781797A7 (fi) Foerfarande foer framstaellning av imidazo (1,2-a) pyridiner
NL190573C (nl) Farmaceutisch preparaat met diuretische, antihypertensieve en cardiale werking, alsmede 2,4,7-triamino-6-fenylpteridineverbindingen.
FI874400A7 (fi) Foerfarande foer framstaellning av imidazo-4,5-b pyridin-2-on-derivat.
FI821332A7 (fi) Sydänlääkkeinä käyttökelpoisia pyratsolipyridiinijohdannaisia sekä niiden valmistus.

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 980522